Table 1.
(single close, 80mg/kg, PO)
| |||||
---|---|---|---|---|---|
Experimental period (days) | PAS | Collagen type IV | Laminin | Fibronectin | CSPG |
Control | N | N | N | Nb | N |
0.5 | N | N | N | Nb | N |
1 | N | N | N | Nb | N |
3 | Na | + | + | + | +c |
7 | + | ++ | ++ | ++ | +c |
14 | ++ | +++ | +++ | +++ | N |
28 | +++ | +++ | +++ | +++ | N |
56 | +++ | ++ | +++ | ++ | N |
PO: per oral administration
CSPG: chondroitin sulfate proteoglycan
PAS: periodic acid Schiff stain
N: no change of GBM components compared with control rats
Na: mild mesangial widening only
Nb: thin, segmental immunohistochemical reaction
+, ++, +++: degree of GBM component thickening (mild, moderate, severe)
+c: mild segmental thickening